Although the TME polarizes TAN to N2, angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II type 1 receptor (AGTR1) antagonists can polarize it toward N1 to attenuate tumor growth [45]. Here, AGTR1 is linked to neoplasm.